Moreover, BMI1-positive CSCs are slow-cycling, tumor initiating SCs (4) which can give rise to entire regions in OSCCs (17) and are responsible for mediating lymph node metastasis, therapy resistance, and tumor relapse (16). The gene discussed is BMI1; the disease is neoplasm.